Emcure Pharmaceuticals Performance
- Today's Low
- ₹1,786
- Today's High
- ₹1,840
- 52 Week Low
- ₹1,260
- 52 Week High
- ₹1,944
- Open Price₹1,790
- Previous Close₹1,793
- Volume138,088
- 50 DMA₹1,748.92
- 100 DMA₹1,671.34
- 200 DMA₹1,571.85
Emcure Pharmaceuticals Chart
Investment Returns
- Over 1 Month + 4.26%
- Over 3 Month + 11.02%
- Over 6 Month + 16.74%
- Over 1 Year + 39.54%
Smart Investing Starts Here Start SIP with Emcure Pharmaceuticals for Steady Growth!
Emcure Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 37.1
- PEG Ratio
- 1
- Market Cap Cr
- 34,334
- P/B Ratio
- 6.9
- Average True Range
- 54.98
- EPS
- 49.88
- Dividend Yield
- 0.2
- MACD Signal
- 29
- RSI
- 53.66
- MFI
- 56.6
Latest Stock News Updates
Ownership consolidation follows the mRNA business carve-out as Emcure reshapes Gennova's strategy to sharpen its focus on biologics, biosimilars and adjacent therapeutic platforms
- Business Standard
- 1 day 11 hours ago
The rise in profits was attributed to the robust performance in international markets and growth in new launches from Emcure's in-house portfolio
- Business Standard
- 2 months 1 week ago
Conference Call with Emcure Pharmaceuticals Management and Analysts on Q4FY26 Performance and Outlook. Listen to the full earnings transcript.
- Trendlyne
- 2 months 1 week ago
Emcure Pharmaceuticals Financials
Emcure Pharmaceuticals Technicals
EMA & SMA
- Bearish Moving Average 5
- Bullish Moving Average 11
- 20 Day
- ₹1,803.60
- 50 Day
- ₹1,748.90
- 100 Day
- ₹1,671.30
- 200 Day
- ₹1,571.80
Resistance and Support
- R3 1,891.93
- R2 1,865.97
- R1 1,838.03
- S1 1,784.13
- S2 1,758.17
- S3 1,730.23
Emcure Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
About Emcure Pharmaceuticals
- NSE Symbol
- EMCURE
- BSE Symbol
- 544210
- Managing Director & CEO
- Mr. Satish Ramanlal Mehta
- ISIN
- INE168P01015
Similar Stocks to Emcure Pharmaceuticals
Popular Stocks
Emcure Pharmaceuticals FAQs
Emcure Pharmaceuticals share price is ₹1,810 As on 15 July, 2026 | 04:55
The Market Cap of Emcure Pharmaceuticals is ₹34334 Cr As on 15 July, 2026 | 04:55
The P/E ratio of Emcure Pharmaceuticals is 37.1 As on 15 July, 2026 | 04:55
The PB ratio of Emcure Pharmaceuticals is 6.9 As on 15 July, 2026 | 04:55
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.